ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
Gennari, A., André, F., Barrios, C.H., Cortés, J., de Azambuja, E., DeMichele, A., Dent, R., Fenlon, D., Gligorov, J., Hurvitz, S.A., Im, S.-A., Krug, D., Kunz, W.G., Loi, S., Penault-Llorca, F., Ricke, J., Robson, M., Rugo, H.S., Saura, C., Schmid, P., Singer, C.F., Spanic, T., Tolaney, S.M., Turner, N.C., Curigliano, G., Loibl, S., Paluch-Shimon, S., Harbeck, N.
Published in Annals of oncology (01.12.2021)
Published in Annals of oncology (01.12.2021)
Get full text
Journal Article
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
Cardoso, F., Paluch-Shimon, S., Senkus, E., Curigliano, G., Aapro, M.S., André, F., Barrios, C.H., Bergh, J., Bhattacharyya, G.S., Biganzoli, L., Boyle, F., Cardoso, M.-J., Carey, L.A., Cortés, J., El Saghir, N.S., Elzayat, M., Eniu, A., Fallowfield, L., Francis, P.A., Gelmon, K., Gligorov, J., Haidinger, R., Harbeck, N., Hu, X., Kaufman, B., Kaur, R., Kiely, B.E., Kim, S.-B., Lin, N.U., Mertz, S.A., Neciosup, S., Offersen, B.V., Ohno, S., Pagani, O., Prat, A., Penault-Llorca, F., Rugo, H.S., Sledge, G.W., Thomssen, C., Vorobiof, D.A., Wiseman, T., Xu, B., Norton, L., Costa, A., Winer, E.P.
Published in Annals of oncology (01.12.2020)
Published in Annals of oncology (01.12.2020)
Get full text
Journal Article
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
Miles, D., Gligorov, J., Cameron, D., Xu, B., Semiglazov, V., Reinisch, M., Patre, M., Morales, L., Patel, S.L., Barata, T., Xu, B., Shao, Z., Wang, X., Geng, C., Yan, X., Tong, Z., Sun, T., Yang, J., Liu, Q., Zhang, S., De Laurentiis, M., Santoro, A., Colleoni, M., Cortesi, L., Placido, S., Ferrau, F., Del Mastro, L., Tonini, G., Montemurro, F., Bianchi, G., Prete, S., Allegrini, G., Naso, G., Vici, P., Loirat, D., Tredan, O., Gligorov, J., Timar David, M., Dohollou, N., Spano, J.-P., Mansi, L., Andrade, L., Damian, F., Aleixo, S., Junior, R., Reinisch, M., Grischke, E.-M., Harbeck, N., Peters, U., Fischer, D., Forstbauer, H., Warner, E., Bouganim, N., Vandenberg, T., Pavic, M., Robinson, A., Califaretti, N., Alacacioglu, A., Gumus, M., Yalcin, B., Cicin, I., Kose, F., Cubukcu, E., Wardley, A., Miles, D., Gupta, S., Mohapatra, P., Ghadyalpatil, N., Singhal, M., Agarwal, A., Wolf, I., Gal Yam, E., Yerushalmi, R., Peretz, T., Ben Baruch, N., Hamilton, E., Brufsky, A., Wright, G., Graff, S., Semiglazov, V., Ruiz Borrego, M., Merino, L., Guerra Martinez, J., Ohtani, S., Inoue, K., Ito, Y., Niikura, N., Sagara, Y., Yanagita, Y., Kaen, D., Nervo, A., Melichar, B., Sormova, P., Sufliarsky, J., Kakalejcik, M., Belbaraka, R., Errihani, H., Le Than, D., Pham, D., Papandreou, C.
Published in Annals of oncology (01.08.2021)
Published in Annals of oncology (01.08.2021)
Get full text
Journal Article
High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers
Palich, R., Veyri, M., Vozy, A., Marot, S., Gligorov, J., Benderra, M.-A., Maingon, P., Morand-Joubert, L., Adjoutah, Z., Marcelin, A.-G., Spano, J.-P., Barrière, J.
Published in Annals of oncology (01.10.2021)
Published in Annals of oncology (01.10.2021)
Get full text
Journal Article
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
Cardoso, F., Costa, A., Norton, L., Senkus, E., Aapro, M., André, F., Barrios, C.H., Bergh, J., Biganzoli, L., Blackwell, K.L., Cardoso, M.J., Cufer, T., El Saghir, N., Fallowfield, L., Fenech, D., Francis, P., Gelmon, K., Giordano, S.H., Gligorov, J., Goldhirsch, A., Harbeck, N., Houssami, N., Hudis, C., Kaufman, B., Krop, I., Kyriakides, S., Lin, U.N., Mayer, M., Merjaver, S.D., Nordström, E.B., Pagani, O., Partridge, A., Penault-Llorca, F., Piccart, M.J., Rugo, H., Sledge, G., Thomssen, C., van't Veer, L., Vorobiof, D., Vrieling, C., West, N., Xu, B., Winer, E.
Published in Annals of oncology (01.10.2014)
Published in Annals of oncology (01.10.2014)
Get full text
Journal Article
Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study
Pivot, X., Gligorov, J., Müller, V., Curigliano, G., Knoop, A., Verma, S., Jenkins, V., Scotto, N., Osborne, S., Fallowfield, L., Fallowfield, Lesley, Jenkins, Valerie, Kilkerr, Justine, Langridge, Carolyn, Monson, Kathryn, Jakobsen, Erik Hugger, Nielsen, Mette Holck, Linnet, Soeren, Knoop, Ann, Pivot, Xavier, Bonnefoi, Herve, Mousseau, Mireille, Zelek, Laurent, Bourgeois, Hugues, Lefeuvre, Claudia Plesse, Bachelot, Thomas, Petit, Thierry, Brain, Etienne, Levy, Christelle, Gligorov, Joseph, Augustin, Doris, Graf, Heiko, Heinrich, Georg, Kroening, Hendrik, Kuemmel, Sherko, Müller, Volkmar, Overkamp, Friedrich, Park-Simon, Tjoung-Won, Schmidt, Marcus, Perlova-Griff, Lidia, Wolf, Christopher, Colleoni, Marco, Ballestrero, Alberto, Bernardo, Antonio, Ribecco, Angela Stefania, Gianni, Luca, Curigliano, Giuseppe, Brewczynska, Elżbieta, Jassem, Jacek, Shirinkin, Vadim, Manikhas, Alexey, Dvornichenko, Victoria, Lichinitser, Mikhail, Semiglazov, Vladimir, Mukhametshina, Guzel, Bulavina, Irina, Arranz, Enrique Espinosa, Ocon, Francisco Carabantes, Vivanco, Guillermo López, Bofill, Javier Salvador, Quintela, Ignacio Porras, Muñoz, Alfonso Sanchez, Pérez, Yolanda Fernández, Espinosa, Javier Cassinello, Alvarez, José Valero, del Prado, Rodrigo Lastra, De Merino, LuisLa Cruz, García, José Manuel Pérez, Frances, Santos Enrech, Edlund, Per, Norberg, Bengt, Wennstig, Anna-Karin, Lind, Pehr, Hauser, Nik, Tausch, Christoph, Camci, Celalettin, Arpaci, Fikret, Abali, Huseyin, Uslu, Ruchan, Tahir, Saad, Wheatley, Duncan, Chan, Stephen, Barrett-Lee, Peter, McAdam, Karen, Simcock, Richard, Burcombe, Russell, El-Maraghi, Robert, Califaretti, Nadia, Spadafora, Silvana, Sehdev, Sandeep, Sami, Amer, Verma, Sunil
Published in Annals of oncology (01.10.2014)
Published in Annals of oncology (01.10.2014)
Get full text
Journal Article
Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study
Pivot, X., Verma, S., Fallowfield, L., Müller, V., Lichinitser, M., Jenkins, V., Sánchez Muñoz, A., Machackova, Z., Osborne, S., Gligorov, J.
Published in European journal of cancer (1990) (01.11.2017)
Published in European journal of cancer (1990) (01.11.2017)
Get full text
Journal Article
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
Cardoso, F, Costa, A, Norton, L, Senkus, E, Aapro, M, André, F, Barrios, C.H, Bergh, J, Biganzoli, L, Blackwell, K.L, Cardoso, M.J, Cufer, T, El Saghir, N, Fallowfield, L, Fenech, D, Francis, P, Gelmon, K, Giordano, S.H, Gligorov, J, Goldhirsch, A, Harbeck, N, Houssami, N, Hudis, C, Kaufman, B, Krop, I, Kyriakides, S, Lin, U.N, Mayer, M, Merjaver, S.D, Nordström, E.B, Pagani, O, Partridge, A, Penault-Llorca, F, Piccart, M.J, Rugo, H, Sledge, G, Thomssen, C, van’t Veer, L, Vorobiof, D, Vrieling, C, West, N, Xu, B, Winer, E
Published in Breast (Edinburgh) (01.10.2014)
Published in Breast (Edinburgh) (01.10.2014)
Get full text
Journal Article
Conference Proceeding
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
Gourgou-Bourgade, S., Cameron, D., Poortmans, P., Asselain, B., Azria, D., Cardoso, F., A'Hern, R., Bliss, J., Bogaerts, J., Bonnefoi, H., Brain, E., Cardoso, M.J., Chibaudel, B., Coleman, R., Cufer, T., Dal Lago, L., Dalenc, F., De Azambuja, E., Debled, M., Delaloge, S., Filleron, T., Gligorov, J., Gutowski, M., Jacot, W., Kirkove, C., MacGrogan, G., Michiels, S., Negreiros, I., Offersen, B.V., Penault Llorca, F., Pruneri, G., Roche, H., Russell, N.S., Schmitt, F., Servent, V., Thürlimann, B., Untch, M., van der Hage, J.A., van Tienhoven, G., Wildiers, H., Yarnold, J., Bonnetain, F., Mathoulin-Pélissier, S., Bellera, C., Dabakuyo-Yonli, T.S.
Published in Annals of oncology (01.05.2015)
Published in Annals of oncology (01.05.2015)
Get full text
Journal Article
Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study
Pivot, X., Spano, J.P., Espie, M., Cottu, P., Jouannaud, C., Pottier, V., Moreau, L., Extra, J.M., Lortholary, A., Rivera, P., Spaeth, D., Attar-Rabia, H., Benkanoun, C., Dima-Martinez, L., Esposito, N., Gligorov, J.
Published in European journal of cancer (1990) (01.09.2017)
Published in European journal of cancer (1990) (01.09.2017)
Get full text
Journal Article
1st International consensus guidelines for advanced breast cancer (ABC 1)
Cardoso, F, Costa, A, Norton, L, Cameron, D, Cufer, T, Fallowfield, L, Francis, P, Gligorov, J, Kyriakides, S, Lin, N, Pagani, O, Senkus, E, Thomssen, C, Aapro, M, Bergh, J, Di Leo, A, El Saghir, N, Ganz, P.A, Gelmon, K, Goldhirsch, A, Harbeck, N, Houssami, N, Hudis, C, Kaufman, B, Leadbeater, M, Mayer, M, Rodger, A, Rugo, H, Sacchini, V, Sledge, G, van’t Veer, L, Viale, G, Krop, I, Winer, E
Published in Breast (Edinburgh) (01.06.2012)
Published in Breast (Edinburgh) (01.06.2012)
Get full text
Journal Article
Conference Proceeding
Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program
Bello Roufai, D, Gonçalves, A, De La Motte Rouge, T, Akla, S, Blonz, C, Grenier, J, Gligorov, J, Saghatchian, M, Bailleux, C, Simon, H, Desmoulins, I, Tharin, Z, Renaud, E, Bertho, M, Benderra, M-A, Delaloge, S, Robert, L, Cottu, P, Pierga, J Y, Loirat, D, Bertucci, A, Renouf, B, Bidard, F C, Lerebours, F
Published in Oncogene (01.04.2023)
Published in Oncogene (01.04.2023)
Get full text
Journal Article
Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program
Bello Roufai, D, Gonçalves, A, De La Motte Rouge, T, Akla, S, Blonz, C, Grenier, J, Gligorov, J, Saghatchian, M, Bailleux, C, Simon, H, Desmoulins, I, Tharin, Z, Renaud, E, Bertho, M, Benderra, M-A, Delaloge, S, Robert, L, Cottu, P, Pierga, J Y, Loirat, D, Bertucci, A, Renouf, B, Bidard, F C, Lerebours, F
Published in Oncogene (06.06.2023)
Published in Oncogene (06.06.2023)
Get full text
Journal Article
Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact
Nabholtz, J.M., Abrial, C., Mouret-Reynier, M.A., Dauplat, M.M., Weber, B., Gligorov, J., Forest, A.M., Tredan, O., Vanlemmens, L., Petit, T., Guiu, S., Van Praagh, I., Jouannaud, C., Dubray-Longeras, P., Tubiana-Mathieu, N., Benmammar, K.E., Kullab, S., Bahadoor, M.R.K., Radosevic-Robin, N., Kwiatkowski, F., Desrichard, A., Cayre, A., Uhrhammer, N., Chalabi, N., Chollet, P., Penault-Llorca, F.
Published in Annals of oncology (01.08.2014)
Published in Annals of oncology (01.08.2014)
Get full text
Journal Article
Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab
Pierga, J.-Y., Bidard, F.-C., Autret, A., Petit, T., Andre, F., Dalenc, F., Levy, C., Ferrero, J.-M., Romieu, G., Bonneterre, J., Lerebours, F., Bachelot, T., Kerbrat, P., Campone, M., Eymard, J.-C., Mouret-Reynier, M.-A., Gligorov, J., Hardy-Bessard, A.-C., Lortholary, A., Soulie, P., Boher, J.-M., Proudhon, C., Charafe-Jaufret, E., Lemonnier, J., Bertucci, F., Viens, P.
Published in Annals of oncology (01.01.2017)
Published in Annals of oncology (01.01.2017)
Get full text
Journal Article
Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients
Palich, R., Veyri, M., Marot, S., Vozy, A., Gligorov, J., Maingon, P., Marcelin, A.-G., Spano, J.-P.
Published in Annals of oncology (01.08.2021)
Published in Annals of oncology (01.08.2021)
Get full text
Journal Article
Real-life utilization of genomic testing for invasive breast cancer patients in Italy and France reduces chemotherapy recommendations
Barni, S., Curtit, E., Cognetti, F., Bourgeois, D., Masetti, R., Zilberman, S., Naso, G., Gligorov, J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer
Vrdoljak, E., Marschner, N., Zielinski, C., Gligorov, J., Cortes, J., Puglisi, F., Aapro, M., Fallowfield, L., Fontana, A., Inbar, M., Kahan, Z., Welt, A., Lévy, C., Brain, E., Pivot, X., Putzu, C., González Martín, A., de Ducla, S., Easton, V., von Minckwitz, G.
Published in Annals of oncology (01.11.2016)
Published in Annals of oncology (01.11.2016)
Get full text
Journal Article